+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

High-content Screening Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • ID: 4702606
  • Report
  • October 2018
  • Region: Global
  • 100 pages
  • Infinium Global Research

FEATURED COMPANIES

  • BioTek Instruments, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Merck Millipore
  • Perkinelmer, Inc.
  • Tecan Trading AG
The report on global high-content screening market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global high-content screening market to grow with a CAGR of 10.1% over the forecast period of 2018-2024. The study on high-content screening market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The report on high-content screening market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global high-content screening market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global high-content screening market over the period of 2016 to 2024. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:

1. Key Opinion Leaders associated

2. Internal and External subject matter experts

3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Primary research respondents typically include:

1. Executives working with leading companies in the market under review

2. Product/brand/marketing managers

3. CXO level executives

4. Regional/zonal/country managers

5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications

2. Government/institutional publications

3. Trade and associations journals

4. Databases such as WTO, OECD, World Bank, and among others.

5. Websites and publications by research agencies

Report Findings

1. Drivers
  • Latest Development in the High-Content Screening (Hcs) Technology and Its Significance in Drug Discovery
  • Introduction of Several New Products by the Market Players
2. Restraints
  • High Price of High Contents Screening Instruments
3. Opportunities
  • Growing Government Funding Helps to Research and Development for Drug Discovery
Segment Covered

The global high-content screening market is segmented on the basis of application , end user and product.

Global High-content Screening Market by Application
  • Explorative Screening
  • Neurobiology
  • Toxicology
  • Oncology
  • Target Validation
  • Others
Global High-content Screening Market by End User
  • Pharmaceutical And Healthcare
  • Biotechnology
  • Educational Instituations
  • Independent CRO
  • Government Organizations
  • Others
Global High-content Screening Market by Product
  • Accessories
  • Consumables
  • Software
  • Services
  • Instruments
  • Reagents
  • Others
Company Profiles
  • Merck Millipore
  • Bio-Rad Laboratories, Inc.
  • Tecan Trading AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Perkinelmer, Inc.
  • BioTek Instruments, Inc.
  • GE Healthcare
  • Cell Signalling Technologies, Inc.
What does this report deliver?

1. Comprehensive analysis of global as well as regional markets of high-content screening market.

2. Complete coverage of all the segments in high-content screening market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in global high-content screening market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. The Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BioTek Instruments, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Merck Millipore
  • Perkinelmer, Inc.
  • Tecan Trading AG
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. High-Content Screening Market Highlights
2.2. High-Content Screening Market Projection
2.3. High-Content Screening Market Regional Highlights

3. Global High-Content Screening Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Application
3.4.2. Growth Matrix Analysis by End User
3.4.3. Growth Matrix Analysis by Product
3.4.4. Growth Matrix Analysis by Region
3.5. Value chain High-Content Screening Market

4. High-Content Screening Market macro indicator analysis

5. Global High-Content Screening Market by Application
5.1. Explorative Screening
5.2. Neurobiology
5.3. Toxicology
5.4. Oncology
5.5. Target Validation
5.6. Others

6. Global High-Content Screening Market by End User
6.1. Pharmaceutical And Healthcare
6.2. Biotechnology
6.3. Educational Instituations
6.4. Independent CRO
6.5. Government Organizations
6.6. Others

7. Global High-Content Screening Market by Product
7.1. Accessories
7.2. Consumables
7.3. Software
7.4. Services
7.5. Instruments
7.6. Reagents
7.7. Others

8. Global High-Content Screening Market by Region 2018-2024
8.1. North America
8.1.1. North America High-Content Screening Market by Application
8.1.2. North America High-Content Screening Market by End User
8.1.3. North America High-Content Screening Market by Product
8.1.4. North America High-Content Screening Market by Country
8.2. Europe
8.2.1. Europe High-Content Screening Market by Application
8.2.2. Europe High-Content Screening Market by End User
8.2.3. Europe High-Content Screening Market by Product
8.2.4. Europe High-Content Screening Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific High-Content Screening Market by Application
8.3.2. Asia-Pacific High-Content Screening Market by End User
8.3.3. Asia-Pacific High-Content Screening Market by Product
8.3.4. Asia-Pacific High-Content Screening Market by Country
8.4. RoW
8.4.1. RoW High-Content Screening Market by Application
8.4.2. RoW High-Content Screening Market by End User
8.4.3. RoW High-Content Screening Market by Product
8.4.4. RoW High-Content Screening Market by Sub-region

9. Company profiles and competitive landscape
9.1. Competitive Landscape in the Global High-Content Screening Market
9.2. Companies Profiles
9.2.1. Merck Millipore
9.2.1.1. Overview
9.2.1.2. Company Snapshot
9.2.1.3. Financial Snapshot
9.2.1.4. Product portfolio
9.2.1.5. Recent developments
9.2.2. Bio-Rad Laboratories, Inc.
9.2.2.1. Overview
9.2.2.2. Company Snapshot
9.2.2.3. Financial Snapshot
9.2.2.4. Product portfolio
9.2.2.5. Recent developments
9.2.3. Tecan Trading AG
9.2.3.1. Overview
9.2.3.2. Company Snapshot
9.2.3.3. Financial Snapshot
9.2.3.4. Product portfolio
9.2.3.5. Recent developments
9.2.4. Danaher Corporation
9.2.4.1. Overview
9.2.4.2. Company Snapshot
9.2.4.3. Financial Snapshot
9.2.4.4. Product portfolio
9.2.4.5. Recent developments
9.2.5. Thermo Fisher Scientific Inc.
9.2.5.1. Overview
9.2.5.2. Company Snapshot
9.2.5.3. Financial Snapshot
9.2.5.4. Product portfolio
9.2.5.5. Recent developments
9.2.6. Perkinelmer, Inc.
9.2.6.1. Overview
9.2.6.2. Company Snapshot
9.2.6.3. Financial Snapshot
9.2.6.4. Product portfolio
9.2.6.5. Recent developments
9.2.7. BioTek Instruments, Inc.
9.2.7.1. Overview
9.2.7.2. Company Snapshot
9.2.7.3. Financial Snapshot
9.2.7.4. Product portfolio
9.2.7.5. Recent developments
9.2.8. GE Healthcare
9.2.8.1. Overview
9.2.8.2. Company Snapshot
9.2.8.3. Product portfolio
9.2.8.4. Recent developments
9.2.9. Cell Signalling Technologies, Inc
9.2.9.1. Overview
9.2.9.2. Company Snapshot
9.2.9.3. Product portfolio
9.2.9.4. Recent developments

10. Appendix
10.1. Primary research findings and questionnaire
Note: Product cover images may vary from those shown
  • Merck Millipore
  • Bio-Rad Laboratories, Inc.
  • Tecan Trading AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Perkinelmer, Inc.
  • BioTek Instruments, Inc.
  • GE Healthcare
  • Cell Signalling Technologies, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll